Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02067390 · ClinicalTrials.gov registry record
Urinary KIM-1 After Vancomycin or Linezolid Administration
A clinical trial, sponsored by Midwestern University.
- Terminated
- Registry status
- 5
- Enrollment target
NCT02067390: Clinical Trial study, sponsored by Midwestern University.
NCT02067390 is a clinical trial that was terminated before completion, run by Midwestern University. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02067390 was terminated before completion, sponsored by Midwestern University.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
Acute renal injury is a common complication of critical illness. Drug induced renal insult compounds the degree of injury in many patients, and a great deal of research has focused on prevention of this complication. Traditional biomarkers of renal injury like serum creatinine and blood urea nitrogen content fail to consistently predict harm among patients at risk. Kidney Injury Molecule 1 (KIM-1) will be studied as a biomarker of renal injury.
Primary Outcome
Urinary KIM-1 concentrations will be compared between patients receiving vancomycin and linezolid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2013-09 |
| Est. Completion | 2019-05 |
Why NCT02067390 stopped before completion
NCT02067390 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02067390 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02067390 about?
NCT02067390 is a clinical study titled "Urinary KIM-1 After Vancomycin or Linezolid Administration". Acute renal injury is a common complication of critical illness. Drug induced renal insult compounds the degree of injury in many patients, and a great deal of research has focused on prevention of this complication. Traditional biomarkers of renal injury like serum creatinine and blood urea nitroge...
What is the current status of trial NCT02067390?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2013-09. Estimated completion is 2019-05.
Who is sponsoring clinical trial NCT02067390?
This trial is sponsored by Midwestern University, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia